Literature DB >> 7545494

Generation and characterization of a delta F508 cystic fibrosis mouse model.

W H Colledge1, B S Abella, K W Southern, R Ratcliff, C Jiang, S H Cheng, L J MacVinish, J R Anderson, A W Cuthbert, M J Evans.   

Abstract

We have generated mice carrying the most common mutation in cystic fibrosis (CF), delta F508, within the cystic fibrosis (Cftr) gene. Mutant animals show pathological and electrophysiological changes consistent with a CF phenotype. delta F508-/- mice die from peritonitis and show deficiencies in cAMP-activated electrogenic Cl- transport. These mice produce delta F508 transcripts and show the temperature-dependent trafficking defect first described for the human delta F508 CFTR protein. A functional CFTR Cl- channel not demonstrated by null CF mice or present at 37 degrees C was detected following incubation of epithelial cells at 27 degrees C. Thus, these mice are an accurate delta F508 model and will be valuable for testing drugs aimed at overcoming the delta F508 trafficking defect.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545494     DOI: 10.1038/ng0895-445

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  69 in total

1.  Chloride secretion in the trachea of null cystic fibrosis mice: the effects of transfection with pTrial10-CFTR2.

Authors:  L J MacVinish; D R Gill; S C Hyde; K A Mofford; M J Evans; C F Higgins; W H Colledge; L Huang; F Sorgi; R Ratcliff; A W Cuthbert
Journal:  J Physiol       Date:  1997-03-15       Impact factor: 5.182

Review 2.  The unfolded protein response in protein aggregating diseases.

Authors:  Alexander Gow; Ramaswamy Sharma
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

3.  Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung.

Authors:  G B Pier; M Grout; T S Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice.

Authors:  Mathilde Beka; Teresinha Leal
Journal:  J Vis Exp       Date:  2018-07-04       Impact factor: 1.355

5.  Processing and function of CFTR-DeltaF508 are species-dependent.

Authors:  Lynda S Ostedgaard; Christopher S Rogers; Qian Dong; Christoph O Randak; Daniel W Vermeer; Tatiana Rokhlina; Philip H Karp; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-14       Impact factor: 11.205

6.  Generation and characterization of a complete null estrogen receptor alpha mouse using Cre/LoxP technology.

Authors:  Ming Chen; Andrew Wolfe; Xi Wang; Chawnshang Chang; Shuyuan Yeh; Sally Radovick
Journal:  Mol Cell Biochem       Date:  2008-10-25       Impact factor: 3.396

Review 7.  Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.

Authors:  Kevin W Southern; Sanjay Patel; Ian P Sinha; Sarah J Nevitt
Journal:  Cochrane Database Syst Rev       Date:  2018-08-02

8.  An ovine CFTR variant as a putative cystic fibrosis causing mutation.

Authors:  S J Tebbutt; A Harris; D F Hill
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

Review 9.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

10.  Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection.

Authors:  Fadie T Coleman; Simone Mueschenborn; Gloria Meluleni; Christopher Ray; Vincent J Carey; Sara O Vargas; Carolyn L Cannon; Frederick M Ausubel; Gerald B Pier
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.